Pioglitazone for the treatment of type 2 diabetes in patients inadequately controlled on insulin

Stanley S SchwartzDiabetes Disease Management at the University of Pennsylvania, Penn Presbyterian Medical Center, Philadelphia Heart Institute, Philadelphia, Pennsylvania, USAAbstract: Insulin resistance and impaired beta-cell function are primary defects that occur early in the course of developme...

Full description

Bibliographic Details
Main Author: Schwartz S
Format: Article
Language:English
Published: Dove Medical Press 2010-07-01
Series:Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy
Subjects:
Online Access:https://www.dovepress.com/pioglitazone-for-the-treatment-of-type-2-diabetes-in-patients-inadequa-peer-reviewed-article-DMSO